PORTLAND, Ore., Oct. 15, 2014 (SEND2PRESS NEWSWIRE) — Paragon BioTeck, Inc., a privately held biopharmaceutical and medical device company specializing in the development of ophthalmic pharmaceuticals, devices and therapies, will be exhibiting at the American Academy of Ophthalmology (Booth #4550) in Chicago, Ill., on October 18 – 21.
PLYMOUTH, Minn., Oct. 14, 2014 (SEND2PRESS NEWSWIRE) — SilkTears, LLC, a privately held, research-based and product-driven biotechnology company, announced today that advances in protein-based excipient technology may allow for the development of artificial tear products that will more closely represent certain characteristics of the natural makeup of the tear film, and may help the significant population of patients suffering from dry eye syndrome.
CLEVELAND, Ohio, July 1, 2014 (SEND2PRESS NEWSWIRE) — Lakewood College is pleased to announce a new payment plan option that will allow students to graduate from the Pharmacy Technician Certificate Program without going thousands of dollars into debt.
PORTLAND, Ore., June 4, 2014 (SEND2PRESS NEWSWIRE) — Paragon BioTeck, Inc., a privately held U.S. biopharmaceutical company specializing in the development of ophthalmic pharmaceuticals and therapies, announces its FDA approved Phenylephrine Hydrochloride Ophthalmic Solution, USP 2.5 percent and 10 percent, to dilate the pupil, is readily available through Bausch + Lomb or your primary wholesaler.
NEW YORK CITY, N.Y., April 9, 2014 (SEND2PRESS NEWSWIRE) — A Louisiana jury has awarded $9 billion to a New York man who developed bladder cancer after taking Actos, Weitz and Luxenberg announced today. The verdict, issued Monday night, orders Takeda Pharmaceuticals to pay $6 billion in punitive damages, and Eli Lilly to pay $3 billion.
PORTLAND, Ore., April 9, 2014 (SEND2PRESS NEWSWIRE) — Paragon BioTeck, Inc., a privately held biopharmaceutical company specializing in the development of ophthalmic pharmaceuticals and therapies, received FDA approval of Phenylephrine Hydrochloride Ophthalmic Solution, USP 2.5 percent and 10 percent, to dilate the pupil on March 21, 2013.
HUNTINGTON BEACH, Calif., Nov. 14, 2013 (SEND2PRESS NEWSWIRE) — SignatureCLL today announced that the first laboratory test ever shown in a clinical trial to improve one year survival rates in cancer is now available to patients with chronic lymphocytic leukemia (also called CLL). The U.S. cancer physician who invented the test and the British scientist who used it to make discoveries in leukemia will offer the test under the trade name SignatuRx(TM) through their own, newly-formed laboratory company.
PORTLAND, Ore., Nov. 8, 2013 (SEND2PRESS NEWSWIRE) — Leading biopharmaceutical company Paragon BioTeck, Inc. announced today that it plans to launch its new line of products, known as Ilast(R), at the Annual American Academy of Ophthalmology meeting in New Orleans. Paragon signed an exclusive distribution agreement with Horus Pharma to supply Ilast(R) ocular care products in the U.S. last month, and the company is excited to release these products to ophthalmology professionals.
CHICAGO, Ill., Nov. 6, 2013 (SEND2PRESS NEWSWIRE) — Natural supplement company Nutronics Labs released a statement today encouraging deer antler spray consumers to do thorough product research before buying health supplements online. Nutronics Labs is the leading manufacturer of deer antler spray and boasts the world’s strongest supplements available – but as the popularity of their products continues to grow, they have seen hundreds of imitation products flood the market recently.
MADISON, N.J. and TIGARD, Ore., April 19, 2013 (SEND2PRESS NEWSWIRE) — Bausch + Lomb, the global eye health company and Paragon BioTeck, Inc. today announced that the companies have entered into a license agreement for Bausch + Lomb to commercialize and distribute Paragon’s phenylephrine in the United States on an exclusive basis beginning this month.
DOVER, Pa. (SEND2PRESS NEWSWIRE) — RXCut(R) Plus announced this week a new website that is designed to help people get the best prescription price available. The Centers for Medicare and Medicaid (CMS) report that in 2014, prescription drug spending is expected to grow at a rate of 10.7 percent.
MILLVILLE, N.J. (SEND2PRESS NEWSWIRE) — Laboratory Supply Distributors Corp., a provider of diverse products for the chromatography, biotechnology, pharmaceutical and environmental industries, this week announced the launch of its 2013 catalog. It showcases many new products for the life science and biotechnology markets.
BRIDGEPORT, Conn. (SEND2PRESS NEWSWIRE) — Head lice love the holidays as much as kids do, says George Coleman, founder of Dermedics Laboratories and master-mind behind the only non-toxic, FDA registered head lice treatment and repellent used by the U.S. Department of Health and Human Services to treat and prevent head lice infestations. Holiday parties give […]
BRIDGEPORT, Conn. (SEND2PRESS NEWSWIRE) — October is the month the kids begin to scratch, says George Coleman, founder and president of Connecticut’s Dermedics Laboratories. That’s because the start of a new school year has children literally putting their heads together – and that’s how head lice infestations get started.
ATLANTA, Ga. (SEND2PRESS NEWSWIRE) — Paul Gondek has joined CMI to expand the company’s Healthcare Solutions practice to support healthcare, pharmaceutical, and medical device companies. As vice president client solutions and healthcare lead, Gondek will further enhance an experienced pharmaceutical team, using advanced analytics and immersive techniques to provide strategic insights that brand teams can use.
ATLANTA, Ga., March 8, 2012 (SEND2PRESS NEWSWIRE) — CMI’s Mike Mabey, vice president, client solutions, and Jarod Ricci, senior manager, market analytics, Pfizer Specialty, will present ‘Using Information-Seeking Behavior to Drive Segment-Specific Communication Strategies’ at the 2012 PMRG (Pharmaceutical Marketing Research Group) Annual National Conference.
PHILADELPHIA, Pa., Feb. 21, 2012 (SEND2PRESS NEWSWIRE) — E’shee Clinical Esthetic announced this week a new addition to its product line of skin serums – Elixir of Life KI Therapy Serum – designed to deliver ultimate skin rejuvenation.
NEW WINDSOR, N.Y., Feb. 14, 2012 (SEND2PRESS NEWSWIRE) — Mary Davidian, M.D., of Highland Ophthalmology Associates, a leading eye surgeon in The Hudson Valley, announces offering her patients a unique corneal wound repair and healing device called ProKera(R). Today, ProKera(R) is the only medical device that can provide wound healing to patients afflicted with a damaged cornea, the outer transparent surface of the eye.
AUSTIN, Texas, Feb. 8, 2012 (SEND2PRESS NEWSWIRE) — Bio-Medical Services has received USDA approval and is now offering allergy drop immunotherapy as an alternative method for administering allergy treatment for pet allergy patients. An in-house pilot study is now underway, and preliminary findings are expected in the Fall of 2012.
MALVERN, Pa., Oct. 31, 2011 (SEND2PRESS NEWSWIRE) — Reaction Biology Corporation (‘RBC’) today announced the publication in Nature Biotechnology, of the largest kinase profiling data set in the public domain, disclosing previously unknown kinase inhibition relationships. The data set was compiled from over 100,000 independent activity assays performed with RBC’s proprietary HotSpot(SM) technology.
MEXICO, Mo., Sept. 20, 2011 (SEND2PRESS NEWSWIRE) — Missouri Gov. Jay Nixon, whose job-creation strategy has focused on investing in science, technology and innovation, and encouraging and incentivizing entrepreneurship, selected Soy Labs and the Missouri Plant Science Center on Friday, as the site to discuss the importance of the Missouri House passing the Missouri Science and Innovation Reinvestment Act (MOSIRA) as part of the Made in Missouri Jobs Package.
PHILADELPHIA, Pa. (SEND2PRESS NEWSWIRE) — E’shee Clinical Esthetic introduces the next step in anti-aging skin care – White Truffle Radiance Cream – an amazingly powerful skin anti-oxidant. This supremely elegant formula combines the finest bioengineering technologies, and offers skin the most effective anti-oxidant protection and luxurious brightening action ever experienced in skincare formulation
SCHWENKSVILLE, Pa. (SEND2PRESS NEWSWIRE) — Millennium Administrators, Inc., a benefits administrator, has signed a contract with the City of Scranton to provide benefit administration services for over 500 city employees. Millennium is providing administrative oversight for the city benefit program, including cost containment initiatives, claim audits and administrative services to enhance cost saving initiatives at the City of Scranton.
MONTREAL, Quebec, Canada (SEND2PRESS NEWSWIRE) — ProtiLife Distribution Inc., a leader in the development and distribution of high-quality protein supplements for over 20 years, has launched its online weight loss program to the U.S. market at www.protilife.com.
VINELAND, N.J. (SEND2PRESS NEWSWIRE) — Designed for analytical research and clinical diagnostic testing, Laboratory Supply Distributors Corp. announces the 96-Well Multi-Tier™ Micro Plate System. Its unique, patented design allows for more flexibility and ease of use.
SAN MARINO, Calif. (SEND2PRESS NEWSWIRE) — Epeius Biotechnologies announced today that the U.S. FDA has granted Phase 3 status for Company’s lead anti-cancer agent, Rexin-G, the first, and so far only, targeted gene delivery system developed to seek-out and destroy metastatic cancer.
PHOENIX, Ariz. (SEND2PRESS NEWSWIRE) — As a part of Business & Decision’s ongoing focus in the Life Science market, we are delighted to announce a partnership with New Strategies, the creators of ‘AX for Pharma’ an industry leading Enterprise Resource Planning solution for the Pharmaceutical industry. This solution, which is based on Microsoft Dynamics AX, has been designed to address the primary business process needs of a Life Science / Pharmaceutical organization.
SOMERSET, N.J. (SEND2PRESS NEWSWIRE) — From the blogosphere to mainstream media, there’s been a recent-and disturbing-buzz on a connection between hormone replacement therapy and a higher risk for advanced-stage breast cancer in post-menopausal women. The recent media focus stems from a study published in the October 2010 issue of the Journal of the American Medical Association (JAMA). Practitioners from Belvidere Pharmacy and Balancing Health, both experts in women’s health, examine the issue.
ATLANTA, Ga. (SEND2PRESS NEWSWIRE) — CMI, a full-service marketing research company, has been chosen for the second consecutive year to present a session at The Fourth Annual Meeting of the PMRG Institute in Boston, MA on Oct. 24-26, 2010. The theme for this year’s conference is ‘Navigating Healthcare’s Shifting Currents: Essential Techniques for the Healthcare Marketing Researcher.’
MALVERN, Pa. (SEND2PRESS NEWSWIRE) — Reaction Biology Corporation (RBC) announced today that it has been awarded a Phase II SBIR grant from the National Cancer Institute to expand the reach of its Methyltransferase HotSpot drug discovery platform. The $1.2 million, two-year grant will help fund an expansion of RBC’s methyltransferase screens from 14 to 35 or more.